Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of an Adapted Physical Activity (APA) for Breast Cancer Patients Treated by Neoadjuvant Chemotherapy and Targeted Therapy Against HER2

NCT02963363 is registered in ClinicalTrials.gov with Centre Jean Perrin as lead sponsor.

NCT NCT02963363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02963363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of an Adapted Physical Activity (APA) for Breast Cancer Patients Treated by Neoadjuvant Chemotherapy and Targeted Therapy Against HER2
Lead sponsor
Centre Jean Perrin
Phase
Not applicable
Overall status
Terminated
Start date
April 27, 2018
Completion date
August 11, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2 positive breast cancer